News & Events IsoPlexis Names PhenoVista Biosciences a Certified Service ProviderPhenoVista Biosciences Announces $1.4M Phase 2 SBIR Grant for Phenotypic Drug Screening in Alzheimer’s DiseaseOlympus and PhenoVista Collaborate to Deliver an Innovative 3D Cell-Based Assay Service for Drug DiscoveryPhenoVista Biosciences and Champions Oncology Announce a Strategic Partnership to provide Oncology Imaging-Based Phenotypic Assays for Preclinical Drug Development
